BackgroundA structural neuroanatomical change indicating a reduction in brain tissue is a
notable feature of schizophrenia. Several pathophysiological processes such as aberrant …

To date, research into the biomarker-aided early recognition of psychosis has focused on
predicting the transition likelihood of clinically defined individuals with different at-risk mental …

Previous network studies in chronic schizophrenia patients revealed impaired structural
organization of the brain's rich-club members, a set of highly interconnected hub regions that …

BACKGROUND: Impaired cortical inhibition is a well-established finding in schizophrenia
patients and has been linked to dysfunctional gamma-aminobutyric acid (GABA) ergic …

BACKGROUND: Several studies have found widespread structural changes affecting the
grey matter at various stages of schizophrenia (the prodrome, first-episode, and the chronic …

It is unclear yet whether cannabis use is a moderating or causal factor contributing to grey
matter alterations in schizophrenia and the development of psychotic symptoms. We …

There is cumulative evidence that young people in an “at-risk mental state”(ARMS) for
psychosis show structural brain abnormalities in frontolimbic areas, comparable to, but less …

Schizophrenia is characterized by heterogeneous brain abnormalities involving cerebral
regions implied in the executive functioning. The dysexecutive syndrome is one of the most …

Antipsychotic drugs, all of which block the dopamine D2 receptor to a greater or lesser
extent, are the mainstay for the pharmacological treatment of schizophrenia. Engaging in a …

Unhealthy lifestyles are damaging to the brain. Previous studies have indicated that body
mass index (BMI), alcohol intake, short sleep, smoking, and lack of exercise are negatively …